These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 26846091)

  • 1. Whole-exome sequencing is a powerful approach for establishing the etiological diagnosis in patients with intellectual disability and microcephaly.
    Rump P; Jazayeri O; van Dijk-Bos KK; Johansson LF; van Essen AJ; Verheij JB; Veenstra-Knol HE; Redeker EJ; Mannens MM; Swertz MA; Alizadeh BZ; van Ravenswaaij-Arts CM; Sinke RJ; Sikkema-Raddatz B
    BMC Med Genomics; 2016 Feb; 9():7. PubMed ID: 26846091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of whole exome sequencing for syndromic retinal dystrophy diagnosis in young patients.
    Prokudin I; Li D; He S; Guo Y; Goodwin L; Wilson M; Rose L; Tian L; Chen Y; Liang J; Keating B; Xu X; Jamieson RV; Hakonarson H
    Clin Exp Ophthalmol; 2015 Mar; 43(2):132-8. PubMed ID: 25060287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asparagine synthetase deficiency detected by whole exome sequencing causes congenital microcephaly, epileptic encephalopathy and psychomotor delay.
    Ben-Salem S; Gleeson JG; Al-Shamsi AM; Islam B; Hertecant J; Ali BR; Al-Gazali L
    Metab Brain Dis; 2015 Jun; 30(3):687-94. PubMed ID: 25227173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel homozygous TRAPPC9 gene mutation causing non-syndromic intellectual disability, speech disorder, and secondary microcephaly.
    Abbasi AA; Blaesius K; Hu H; Latif Z; Picker-Minh S; Khan MN; Farooq S; Khan MA; Kaindl AM
    Am J Med Genet B Neuropsychiatr Genet; 2017 Dec; 174(8):839-845. PubMed ID: 29031008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SLC1A4 mutations cause a novel disorder of intellectual disability, progressive microcephaly, spasticity and thin corpus callosum.
    Heimer G; Marek-Yagel D; Eyal E; Barel O; Oz Levi D; Hoffmann C; Ruzzo EK; Ganelin-Cohen E; Lancet D; Pras E; Rechavi G; Nissenkorn A; Anikster Y; Goldstein DB; Ben Zeev B
    Clin Genet; 2015 Oct; 88(4):327-35. PubMed ID: 26138499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hoyeraal-Hreidarsson syndrome with a DKC1 mutation identified by whole-exome sequencing.
    Lim BC; Yoo SK; Lee S; Shin JY; Hwang H; Chae JH; Hwang YS; Seo JS; Kim JI; Kim KJ
    Gene; 2014 Aug; 546(2):425-9. PubMed ID: 24914498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders.
    Yavarna T; Al-Dewik N; Al-Mureikhi M; Ali R; Al-Mesaifri F; Mahmoud L; Shahbeck N; Lakhani S; AlMulla M; Nawaz Z; Vitazka P; Alkuraya FS; Ben-Omran T
    Hum Genet; 2015 Sep; 134(9):967-80. PubMed ID: 26077850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of exome sequencing for genetic diagnosis in a familial microcephaly epilepsy syndrome.
    McDonell LM; Warman Chardon J; Schwartzentruber J; Foster D; Beaulieu CL; ; Majewski J; Bulman DE; Boycott KM
    BMC Neurol; 2014 Jan; 14():22. PubMed ID: 24479948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive investigation of CASK mutations and other genetic etiologies in 41 patients with intellectual disability and microcephaly with pontine and cerebellar hypoplasia (MICPCH).
    Hayashi S; Uehara DT; Tanimoto K; Mizuno S; Chinen Y; Fukumura S; Takanashi JI; Osaka H; Okamoto N; Inazawa J
    PLoS One; 2017; 12(8):e0181791. PubMed ID: 28783747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical whole exome sequencing in child neurology practice.
    Srivastava S; Cohen JS; Vernon H; Barañano K; McClellan R; Jamal L; Naidu S; Fatemi A
    Ann Neurol; 2014 Oct; 76(4):473-83. PubMed ID: 25131622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and molecular insights into CASK-related disorders in males.
    Moog U; Bierhals T; Brand K; Bautsch J; Biskup S; Brune T; Denecke J; de Die-Smulders CE; Evers C; Hempel M; Henneke M; Yntema H; Menten B; Pietz J; Pfundt R; Schmidtke J; Steinemann D; Stumpel CT; Van Maldergem L; Kutsche K
    Orphanet J Rare Dis; 2015 Apr; 10():44. PubMed ID: 25886057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-Generation Sequencing Reveals Novel Mutations in X-linked Intellectual Disability.
    Muthusamy B; Selvan LDN; Nguyen TT; Manoj J; Stawiski EW; Jaiswal BS; Wang W; Raja R; Ramprasad VL; Gupta R; Murugan S; Kadandale JS; Prasad TSK; Reddy K; Peterson A; Pandey A; Seshagiri S; Girimaji SC; Gowda H
    OMICS; 2017 May; 21(5):295-303. PubMed ID: 28481730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microcephaly thin corpus callosum intellectual disability syndrome caused by mutated TAF2.
    Hellman-Aharony S; Smirin-Yosef P; Halevy A; Pasmanik-Chor M; Yeheskel A; Har-Zahav A; Maya I; Straussberg R; Dahary D; Haviv A; Shohat M; Basel-Vanagaite L
    Pediatr Neurol; 2013 Dec; 49(6):411-416.e1. PubMed ID: 24084144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of a Novel TRMT1 Gene Mutation and Rare GRM1 Gene Defect in Intellectual Disability in Two Azeri Families.
    Davarniya B; Hu H; Kahrizi K; Musante L; Fattahi Z; Hosseini M; Maqsoud F; Farajollahi R; Wienker TF; Ropers HH; Najmabadi H
    PLoS One; 2015; 10(8):e0129631. PubMed ID: 26308914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic basis of DOORS syndrome: an exome-sequencing study.
    Campeau PM; Kasperaviciute D; Lu JT; Burrage LC; Kim C; Hori M; Powell BR; Stewart F; Félix TM; van den Ende J; Wisniewska M; Kayserili H; Rump P; Nampoothiri S; Aftimos S; Mey A; Nair LD; Begleiter ML; De Bie I; Meenakshi G; Murray ML; Repetto GM; Golabi M; Blair E; Male A; Giuliano F; Kariminejad A; Newman WG; Bhaskar SS; Dickerson JE; Kerr B; Banka S; Giltay JC; Wieczorek D; Tostevin A; Wiszniewska J; Cheung SW; Hennekam RC; Gibbs RA; Lee BH; Sisodiya SM
    Lancet Neurol; 2014 Jan; 13(1):44-58. PubMed ID: 24291220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinical parameters with whole exome sequencing analysis results of autosomal recessive patients; a center experience.
    Elmas M; Yıldız H; Erdoğan M; Gogus B; Avcı K; Solak M
    Mol Biol Rep; 2019 Feb; 46(1):287-299. PubMed ID: 30426380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing overrides formal genetics: ASPM mutations in a case study of apparent X-linked microcephalic intellectual deficit.
    Ariani F; Mari F; Amitrano S; Di Marco C; Artuso R; Scala E; Meloni I; Della Volpe R; Rossi A; van Bokhoven H; Renieri A
    Clin Genet; 2013 Mar; 83(3):288-90. PubMed ID: 22823409
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic odyssey in severe neurodevelopmental disorders: toward clinical whole-exome sequencing as a first-line diagnostic test.
    Thevenon J; Duffourd Y; Masurel-Paulet A; Lefebvre M; Feillet F; El Chehadeh-Djebbar S; St-Onge J; Steinmetz A; Huet F; Chouchane M; Darmency-Stamboul V; Callier P; Thauvin-Robinet C; Faivre L; Rivière JB
    Clin Genet; 2016 Jun; 89(6):700-7. PubMed ID: 26757139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel WDR62 mutation causes primary microcephaly in a large consanguineous Saudi family.
    Naseer MI; Rasool M; Sogaty S; Chaudhary RA; Mansour HM; Chaudhary AG; Abuzenadah AM; Al-Qahtani MH
    Ann Saudi Med; 2017; 37(2):148-153. PubMed ID: 28377545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alkylglycerol monooxygenase (AGMO) gene previously involved in autism also causes a novel syndromic form of primary microcephaly in a consanguineous Saudi family.
    Alrayes N; Mohamoud HS; Ahmed S; Almramhi MM; Shuaib TM; Wang J; Al-Aama JY; Everett K; Nasir J; Jelani M
    J Neurol Sci; 2016 Apr; 363():240-4. PubMed ID: 27000257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.